Financhill
Sell
25

OCLN Quote, Financials, Valuation and Earnings

Last price:
$0.0000
Seasonality move :
-13.61%
Day range:
$0.0033 - $0.0039
52-week range:
$0.0018 - $0.0134
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
198.13x
P/B ratio:
--
Volume:
158K
Avg. volume:
675K
1-year change:
-65%
Market cap:
$5.7M
Revenue:
$26.3K
EPS (TTM):
-$0.01
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $3.6M $4.1M $4.1M $26.3K $26.3K
Revenue Growth (YoY) -22.64% 14.31% 1.04% -99.37% --
 
Cost of Revenues $3.2M $3.5M $3.6M -- --
Gross Profit $370.9K $611.8K $569.7K $26.3K $26.3K
Gross Profit Margin 10.34% 14.92% 13.75% -- --
 
R&D Expenses $107.4K $110.3K -- -- --
Selling, General & Admin $4.1M $5.2M $6.5M $5.8M $5.4M
Other Inc / (Exp) -$22.7M $19.2M $5M -$3.7M $9.5M
Operating Expenses $4.3M $5.3M $6.5M $5.9M $5.4M
Operating Income -$3.9M -$4.7M -$5.9M -$5.8M -$5.4M
 
Net Interest Expenses $882.5K $1.3M $1.2M $901.6K $806.2K
EBT. Incl. Unusual Items -$27.5M $13.3M -$2.1M -$10.5M $3.3M
Earnings of Discontinued Ops. -- -- -- -$324.3K -$14.9M
Income Tax Expense -- -- -- -- --
Net Income to Company -$27.5M $13.3M -$2.1M -$10.5M $3.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$27.5M $13.3M -$2.1M -$10.8M -$11.6M
 
Basic EPS (Cont. Ops) -$12.66 $0.64 -$0.02 -$0.02 -$0.01
Diluted EPS (Cont. Ops) -$12.66 $0.04 -$0.02 -$0.02 -$0.01
Weighted Average Basic Share $2.2M $20.7M $180.5M $679M $1.3B
Weighted Average Diluted Share $2.2M $312.4M $180.5M $679M $1.3B
 
EBITDA -$26.7M $14.6M -$845.4K -$9.5M $4.1M
EBIT -$26.7M $14.5M -$890.2K -$9.6M $4.1M
 
Revenue (Reported) $3.6M $4.1M $4.1M $26.3K $26.3K
Operating Income (Reported) -$3.9M -$4.7M -$5.9M -$5.8M -$5.4M
Operating Income (Adjusted) -$26.7M $14.5M -$890.2K -$9.6M $4.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $917.3K $1.1M $3.4M $6.6K --
Revenue Growth (YoY) -2.36% 22.17% 200.36% -99.81% --
 
Cost of Revenues $934.7K $790.3K $2.5M $6.6K $6.4K
Gross Profit -$17.4K $330.4K $823.2K -$10 -$6.4K
Gross Profit Margin -1.9% 29.48% 24.46% -0.14% --
 
R&D Expenses $29.3K -- -- -- --
Selling, General & Admin $1.1M $1.6M $1.8M $947.9K $1.3M
Other Inc / (Exp) $6.4M $20M -$27.8M $1M $1.2M
Operating Expenses $1.2M $1.7M $1.8M $947.9K $1.3M
Operating Income -$1.2M -$1.3M -$984.5K -$947.9K -$1.3M
 
Net Interest Expenses $233K $314.5K $233.4K $183.3K --
EBT. Incl. Unusual Items $5M $18.4M -$29.1M -$126.7K -$176.5K
Earnings of Discontinued Ops. -- -- -- -$3.2M -$2.6M
Income Tax Expense -- -- -- -- --
Net Income to Company $5M $18.4M -$29.1M -$298.9K -$176.5K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $5M $18.4M -$29.1M -$3.3M -$2.8M
 
Basic EPS (Cont. Ops) $0.27 $0.09 -$0.04 -$0.00 -$0.00
Diluted EPS (Cont. Ops) $0.03 $0.02 -$0.04 -$0.00 -$0.00
Weighted Average Basic Share $18.6M $197.7M $775.6M $1.3B $1.6B
Weighted Average Diluted Share $146.1M $795.2M $775.6M $1.3B $1.6B
 
EBITDA $5.3M $18.7M -$28.8M $64.2K -$90.8K
EBIT $5.3M $18.7M -$28.8M $56.6K -$98K
 
Revenue (Reported) $917.3K $1.1M $3.4M $6.6K --
Operating Income (Reported) -$1.2M -$1.3M -$984.5K -$947.9K -$1.3M
Operating Income (Adjusted) $5.3M $18.7M -$28.8M $56.6K -$98K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $4M $3.9M $9.1M -$7.7M --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $3.5M $3M $7.8M -- --
Gross Profit $428.7K $875.1K $1.2M -$1.3M $19.9K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $110.7K -- -- -- --
Selling, General & Admin $4M $7.2M $6.2M $5M $5.3M
Other Inc / (Exp) $6M -$9.4M -$19.7M $29.8M -$3.7M
Operating Expenses $4.2M $7.3M $6.2M $5M $5.3M
Operating Income -$3.8M -$6.4M -$5M -$6.3M -$5.3M
 
Net Interest Expenses $1.1M $1.6M $997.1K $843.1K --
EBT. Incl. Unusual Items $1.2M -$17.4M -$25.6M $22.7M -$9.6M
Earnings of Discontinued Ops. -- -- -- -$10.7M -$9M
Income Tax Expense -- -- -- -- --
Net Income to Company $1.2M -$17.4M -$25.6M $27.8M -$9.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.2M -$17.4M -$25.6M $11.6M -$18.6M
 
Basic EPS (Cont. Ops) -$0.96 -$0.28 -$0.03 $0.03 -$0.01
Diluted EPS (Cont. Ops) -$4.31 -$0.35 -$0.03 $0.03 -$0.01
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $2.2M -$15.8M -$24.6M $23.6M -$9M
EBIT $2.1M -$15.9M -$24.7M $23.5M -$9M
 
Revenue (Reported) $4M $3.9M $9.1M -$7.7M --
Operating Income (Reported) -$3.8M -$6.4M -$5M -$6.3M -$5.3M
Operating Income (Adjusted) $2.1M -$15.9M -$24.7M $23.5M -$9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $3.1M $2.8M $7.8M $19.7K $6.6K
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.7M $2.2M $6.5M $13K $13K
Gross Profit $348.2K $611.5K $1.3M $6.7K -$6.4K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $83.4K -- -- -- --
Selling, General & Admin $2.9M $5M $4.7M $3.9M $4M
Other Inc / (Exp) $23.7M -$5M -$29.7M $3.8M -$4.1M
Operating Expenses $3M $5M $4.8M $3.9M $4M
Operating Income -$2.7M -$4.4M -$3.5M -$3.9M -$4M
 
Net Interest Expenses $595.5K $934.9K $704.5K $645.8K $187K
EBT. Incl. Unusual Items $20.4M -$10.4M -$33.9M -$741.3K -$8.6M
Earnings of Discontinued Ops. -- -- -- -$10.7M -$6.5M
Income Tax Expense -- -- -- -- --
Net Income to Company $20.3M -$10.4M -$33.9M $4.4M -$8.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $20.4M -$10.4M -$33.9M -$11.5M -$15.1M
 
Basic EPS (Cont. Ops) $2.95 -$0.17 -$0.05 -$0.01 -$0.01
Diluted EPS (Cont. Ops) -$0.40 -$0.24 -$0.05 -$0.01 -$0.01
Weighted Average Basic Share $34.7M $442.1M $1.8B $3.6B $4.6B
Weighted Average Diluted Share $256.1M $1B $1.8B $3.6B $4.6B
 
EBITDA $21M -$9.4M -$33.2M -$72.4K -$8.1M
EBIT $21M -$9.4M -$33.2M -$95.4K -$8.1M
 
Revenue (Reported) $3.1M $2.8M $7.8M $19.7K $6.6K
Operating Income (Reported) -$2.7M -$4.4M -$3.5M -$3.9M -$4M
Operating Income (Adjusted) $21M -$9.4M -$33.2M -$95.4K -$8.1M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $490.6K $409.6K $141.4K $790.7K $114.6K
Short Term Investments -- -- $198.9K $27.1K $36.2K
Accounts Receivable, Net $522.9K $438.4K $2.2M -- --
Inventory -- -- $2.9K -- --
Prepaid Expenses $47.5K $52.7K $13.1K $25K --
Other Current Assets -- -- -- -- --
Total Current Assets $1.2M $1.1M $3.5M $5.4M $2.5M
 
Property Plant And Equipment $117.1K $258.2K $213.4K $177.1K $146.7K
Long-Term Investments $9.6K $8K $17.6K $402.4K $403.2K
Goodwill -- -- -- -- --
Other Intangibles $4.5K $4.5K $4.5K $4.5K $4.5K
Other Long-Term Assets -- -- $514K $400K --
Total Assets $1.3M $1.3M $4.2M $6.3M $3.1M
 
Accounts Payable $1.1M $1.3M $1.5M $791.2K $647.5K
Accrued Expenses $1.2M $1.5M $1.5M $1.6M $1.8M
Current Portion Of Long-Term Debt $3.1M $2.2M $3.2M $1.2M $2.7M
Current Portion Of Capital Lease Obligations $9.1K $9.1K $8K -- --
Other Current Liabilities $36.6M $17M $7.6M $15.6M $29.1M
Total Current Liabilities $43.1M $22.8M $16.3M $19.6M $34.7M
 
Long-Term Debt $553K $1.9M $62.3K $1.9M $144.8K
Capital Leases -- -- -- -- --
Total Liabilities $43.7M $31M $26.5M $32.4M $42.4M
 
Common Stock $2.2M $9.9K $34K $104.5K $143.1K
Other Common Equity Adj -$130 -$130 -$130 -$130 -$130
Common Equity -$44.6M -$29.6M -$22.3M -$26M -$37M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- -$2.2M
Total Equity -$42.4M -$29.6M -$22.3M -$26M -$39.3M
 
Total Liabilities and Equity $1.3M $1.3M $4.2M $6.3M $3.1M
Cash and Short Terms $490.6K $409.6K $340.3K $817.8K $150.8K
Total Debt $4M $4M $3.3M $3.1M $2.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $758K $538.7K $484.8K $1.2M $44.2K
Short Term Investments -- -- $45.2K $22.6K $31.7K
Accounts Receivable, Net $503.5K $712K $1.9M $1.5M --
Inventory -- $2.9K $18.4K -- --
Prepaid Expenses $33.6K $32.2K $10.9K $10.2K $10.2K
Other Current Assets -- -- -- -- --
Total Current Assets $1.4M $1.4M $5.2M $3.6M $2.8M
 
Property Plant And Equipment $270.6K $224.2K $185.6K $154.1K $123.8K
Long-Term Investments $10K $40K $4K $403.2K $3.2K
Goodwill -- -- -- -- --
Other Intangibles $4.5K $4.5K $4.5K $4.5K $4.5K
Other Long-Term Assets -- $514K $514K -- $420.4K
Total Assets $1.7M $2.2M $5.9M $4.3M $3.3M
 
Accounts Payable $1.3M $932.2K $2.9M $1.6M $505.9K
Accrued Expenses $1.4M $1.5M $1.6M $2.3M $2.2M
Current Portion Of Long-Term Debt $1.5M $3.2M $1.1M $18.4M $1M
Current Portion Of Capital Lease Obligations $9.1K $9.1K $1.2K -- --
Other Current Liabilities $8.1M $17.6M $36.2M $11.2M $42.5M
Total Current Liabilities $14M $24.4M $43.1M $35.6M $46.8M
 
Long-Term Debt $2.2M $62.3K $2M $144.8K $2M
Capital Leases -- -- -- -- --
Total Liabilities $20.6M $24.5M $56.4M $43.5M $56.9M
 
Common Stock $5.3M $10.2M $93.2K $135K $164.1K
Other Common Equity Adj -$130 -$130 -$130 -$130 -$130
Common Equity -- -- -- -- --
Total Preferred Equity $1.4M $1.2M $1.7M $150K $420K
Minority Interest, Total -- -- -- -- -$2.8M
Total Equity -$18.8M -$22.3M -$50.5M -$39.3M -$53.6M
 
Total Liabilities and Equity $1.7M $2.2M $5.9M $4.3M $3.3M
Cash and Short Terms $758K $538.7K $530K $1.2M $75.8K
Total Debt $4.6M $3.3M $3.1M $18.7M --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$27.5M $13.3M -$2.1M -$10.5M $3.3M
Depreciation & Amoritzation $43.4K $52.3K $44.8K $40K $30.3K
Stock-Based Compensation -- -- $112.4K -- $576.6K
Change in Accounts Receivable -$129K -$39.3K -$1.9M -$1.4M $2M
Change in Inventories -$2.5K -- -$2.9K $2.9K --
Cash From Operations -$3.2M -$4M -$4.8M -$4.6M -$5.5M
 
Capital Expenditures $6.2K $13.9K $18K $21.6K $18K
Cash Acquisitions -- -- -- -$1.1M -$4M
Cash From Investing -$6.2K -$13.9K -$18K -$1.2M -$3.7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- $505K $60K -- $435.9K
Long-Term Debt Repaid -$194.5K -$186.3K -$224.2K -$8K -$208.9K
Repurchase of Common Stock -$65K -- -$25K -- --
Other Financing Activities $40.4K $163.8K $100.5K $58.9K $249.2K
Cash From Financing $3.1M $3.9M $5.2M $6.5M $8.4M
 
Beginning Cash (CF) $609.1K $490.6K $416.1K $706.4K $1.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$118.5K -$74.5K $290.3K $648.4K -$866K
Ending Cash (CF) $490.6K $416.1K $706.4K $1.4M $488.8K
 
Levered Free Cash Flow -$3.2M -$4M -$4.9M -$4.7M -$5.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $5M $18.4M -$29.1M -$298.9K -$176.5K
Depreciation & Amoritzation $14.4K $10.9K $10.2K $7.6K $7.1K
Stock-Based Compensation -- $62.5K -- $420.6K --
Change in Accounts Receivable -$177.6K -$147.1K -$909.2K $120.6K -$117.6K
Change in Inventories -- -- -$400 -- --
Cash From Operations -$1.2M -$1.1M -$1.6M $2M -$1M
 
Capital Expenditures $7.9K $4.5K $8.1K $4.5K --
Cash Acquisitions -- -- -- -$3.3M -$1.6M
Cash From Investing -$7.9K -$4.5K -$8.1K -$576.9K -$424K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $6.3K -- $1.3M $987.8K
Long-Term Debt Repaid -$35.2K -$107.3K -$2.3K -$650 -$281.6K
Repurchase of Common Stock -- -- -$10.5K -- --
Other Financing Activities $39K $11.2K $21.4K $152.5K -$6.4K
Cash From Financing $1.2M $1.1M $1.7M $1.5M $1.4M
 
Beginning Cash (CF) $786.7K $538.8K $1.7M $1.4M $235.5K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$28.7K $20K $50.2K $2.9M $9K
Ending Cash (CF) $758K $558.8K $1.8M $4.3M $244.5K
 
Levered Free Cash Flow -$1.3M -$1.1M -$1.6M $2M -$1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $1.2M -$17.4M -$25.6M $27.8M -$9.7M
Depreciation & Amoritzation $50.5K $46.4K $42.2K $31.5K $28.9K
Stock-Based Compensation -- $62.5K $49.9K $697K $49.3K
Change in Accounts Receivable -$36.1K -$280.1K -$2.6M $1M $544.9K
Change in Inventories -$16.2K -$2.9K -- -- --
Cash From Operations -$3.4M -$4.9M -$4.7M -$2.5M -$7.4M
 
Capital Expenditures $10.6K $18K $21.6K $18K --
Cash Acquisitions -- -- -- -$4.4M -$2.3M
Cash From Investing $18.4K -$18K -$21.6K -$4.1M -$2.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $510K $55K -- $6.5M -$2.9M
Long-Term Debt Repaid -$150.6K -$249K -$9.1K -$3.1K -$805K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $103.2K $154.1K -- $184.6K $170.4K
Cash From Financing $3.6M $4.7M $6M $9.1M $5.6M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $244K -$199.1K $1.2M $2.5M -$4M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$3.4M -$4.9M -$4.8M -$2.5M -$7.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $20.3M -$10.4M -$33.9M $4.4M -$8.6M
Depreciation & Amoritzation $39.9K $34K $31.4K $23K $21.6K
Stock-Based Compensation -- $62.5K -- $697K $169.6K
Change in Accounts Receivable $45.3K -$195.5K -$872.5K $1.6M $122.7K
Change in Inventories -- -$2.9K -$15.6K -- --
Cash From Operations -$2.6M -$3.6M -$3.5M -$1.3M -$3.1M
 
Capital Expenditures $9.4K $13.5K $17.1K $13.5K $4.5K
Cash Acquisitions -- -- -- -$3.3M -$1.6M
Cash From Investing -$9.4K -$13.5K -$17.1K -$3M -$1.5M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $510K $60K -- $6.5M $3.2M
Long-Term Debt Repaid -$159.2K -$221.9K -$6.8K -$1.9K -$598.1K
Repurchase of Common Stock -- -- -$10.5K -- --
Other Financing Activities $112.7K $103K $36.5K $162.2K $83.4K
Cash From Financing $2.9M $3.7M $4.5M $7.2M $4.4M
 
Beginning Cash (CF) $1.6M $1.5M $4.3M $3.6M $1.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $267.3K $142.7K $1M $2.9M -$244.3K
Ending Cash (CF) $1.8M $1.7M $5.3M $6.6M $1.1M
 
Levered Free Cash Flow -$2.6M -$3.6M -$3.5M -$1.3M -$3.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock